HCA Healthcare, Inc. (0J1R.L)
USD 345.74
(0.22%)
USD 345.74
(0.22%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 5.24 Billion USD | -7.11% |
| 2022 | 5.64 Billion USD | -18.88% |
| 2021 | 6.95 Billion USD | 85.3% |
| 2020 | 3.75 Billion USD | 7.1% |
| 2019 | 3.5 Billion USD | -7.45% |
| 2018 | 3.78 Billion USD | 70.89% |
| 2017 | 2.21 Billion USD | -23.32% |
| 2016 | 2.89 Billion USD | 35.74% |
| 2015 | 2.12 Billion USD | 13.55% |
| 2014 | 1.87 Billion USD | 20.5% |
| 2013 | 1.55 Billion USD | -3.05% |
| 2012 | 1.6 Billion USD | -34.89% |
| 2011 | 2.46 Billion USD | 104.23% |
| 2010 | 1.2 Billion USD | 14.52% |
| 2009 | 1.05 Billion USD | 56.61% |
| 2008 | 673 Million USD | -23.0% |
| 2007 | 874 Million USD | -15.64% |
| 2006 | 1.03 Billion USD | -27.25% |
| 2005 | 1.42 Billion USD | 14.29% |
| 2004 | 1.24 Billion USD | -6.46% |
| 2003 | 1.33 Billion USD | 59.9% |
| 2002 | 833 Million USD | -5.98% |
| 2001 | 886 Million USD | 304.57% |
| 2000 | 219 Million USD | -66.67% |
| 1999 | 657 Million USD | 73.35% |
| 1998 | 379 Million USD | 224.26% |
| 1997 | -305 Million USD | -120.27% |
| 1996 | 1.5 Billion USD | 56.61% |
| 1995 | 961 Million USD | 52.54% |
| 1994 | 630 Million USD | 24.26% |
| 1993 | 507 Million USD | 1888.24% |
| 1992 | 25.5 Million USD | 67.76% |
| 1991 | 15.2 Million USD | 55.1% |
| 1990 | 9.8 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 1.27 Billion USD | -13.07% |
| 2024 Q1 | 1.59 Billion USD | -1.0% |
| 2024 Q2 | 1.46 Billion USD | -8.17% |
| 2023 Q2 | 1.19 Billion USD | -12.47% |
| 2023 Q3 | 1.07 Billion USD | -9.56% |
| 2023 Q4 | 1.6 Billion USD | 48.93% |
| 2023 FY | 5.24 Billion USD | -7.11% |
| 2023 Q1 | 1.36 Billion USD | -34.5% |
| 2022 FY | 5.64 Billion USD | -18.88% |
| 2022 Q1 | 1.27 Billion USD | -29.82% |
| 2022 Q2 | 1.15 Billion USD | -9.27% |
| 2022 Q3 | 1.13 Billion USD | -1.82% |
| 2022 Q4 | 2.08 Billion USD | 83.51% |
| 2021 Q3 | 2.26 Billion USD | 56.48% |
| 2021 Q4 | 1.81 Billion USD | -20.05% |
| 2021 FY | 6.95 Billion USD | 85.3% |
| 2021 Q1 | 1.42 Billion USD | -0.21% |
| 2021 Q2 | 1.45 Billion USD | 1.9% |
| 2020 Q4 | 1.42 Billion USD | 113.47% |
| 2020 Q1 | 581 Million USD | -45.75% |
| 2020 Q2 | 1.07 Billion USD | 85.71% |
| 2020 FY | 3.75 Billion USD | 7.1% |
| 2020 Q3 | 668 Million USD | -38.09% |
| 2019 Q4 | 1.07 Billion USD | 75.0% |
| 2019 Q3 | 612 Million USD | -21.84% |
| 2019 Q1 | 1.03 Billion USD | -2.35% |
| 2019 FY | 3.5 Billion USD | -7.45% |
| 2019 Q2 | 783 Million USD | -24.64% |
| 2018 Q1 | 1.14 Billion USD | 141.35% |
| 2018 Q4 | 1.06 Billion USD | 40.18% |
| 2018 FY | 3.78 Billion USD | 70.89% |
| 2018 Q3 | 759 Million USD | -7.44% |
| 2018 Q2 | 820 Million USD | -28.32% |
| 2017 FY | 2.21 Billion USD | -23.32% |
| 2017 Q1 | 659 Million USD | -28.37% |
| 2017 Q2 | 657 Million USD | -0.3% |
| 2017 Q3 | 426 Million USD | -35.16% |
| 2017 Q4 | 474 Million USD | 11.27% |
| 2016 Q3 | 618 Million USD | -6.08% |
| 2016 Q1 | 694 Million USD | 19.24% |
| 2016 FY | 2.89 Billion USD | 35.74% |
| 2016 Q2 | 658 Million USD | -5.19% |
| 2016 Q4 | 920 Million USD | 48.87% |
| 2015 Q1 | 591 Million USD | 12.14% |
| 2015 Q4 | 582 Million USD | 29.62% |
| 2015 Q3 | 449 Million USD | -11.44% |
| 2015 FY | 2.12 Billion USD | 13.55% |
| 2015 Q2 | 507 Million USD | -14.21% |
| 2014 FY | 1.87 Billion USD | 20.5% |
| 2014 Q4 | 527 Million USD | 1.74% |
| 2014 Q3 | 518 Million USD | 7.25% |
| 2014 Q2 | 483 Million USD | 39.19% |
| 2014 Q1 | 347 Million USD | -18.16% |
| 2013 Q4 | 424 Million USD | 16.16% |
| 2013 Q2 | 423 Million USD | 22.97% |
| 2013 FY | 1.55 Billion USD | -3.05% |
| 2013 Q1 | 344 Million USD | 9.55% |
| 2013 Q3 | 365 Million USD | -13.71% |
| 2012 Q2 | 391 Million USD | -27.59% |
| 2012 FY | 1.6 Billion USD | -34.89% |
| 2012 Q4 | 314 Million USD | -12.78% |
| 2012 Q3 | 360 Million USD | -7.93% |
| 2012 Q1 | 540 Million USD | -72.09% |
| 2011 Q1 | 240 Million USD | -15.19% |
| 2011 FY | 2.46 Billion USD | 104.23% |
| 2011 Q4 | 1.93 Billion USD | 3072.13% |
| 2011 Q3 | 61 Million USD | -73.36% |
| 2011 Q2 | 229 Million USD | -4.58% |
| 2010 Q1 | 388 Million USD | 79.63% |
| 2010 Q2 | 293 Million USD | -24.48% |
| 2010 Q4 | 283 Million USD | 16.46% |
| 2010 Q3 | 243 Million USD | -17.06% |
| 2010 FY | 1.2 Billion USD | 14.52% |
| 2009 FY | 1.05 Billion USD | 56.61% |
| 2009 Q3 | 196 Million USD | -30.5% |
| 2009 Q4 | 216 Million USD | 10.2% |
| 2009 Q1 | 360 Million USD | 30.43% |
| 2009 Q2 | 282 Million USD | -21.67% |
| 2008 Q3 | 86 Million USD | -39.01% |
| 2008 Q4 | 276 Million USD | 220.93% |
| 2008 FY | 673 Million USD | -23.0% |
| 2008 Q1 | 170 Million USD | -38.85% |
| 2008 Q2 | 141 Million USD | -17.06% |
| 2007 FY | 874 Million USD | -15.64% |
| 2007 Q1 | 180 Million USD | 47.54% |
| 2007 Q2 | 116 Million USD | -35.56% |
| 2007 Q3 | 300 Million USD | 158.62% |
| 2007 Q4 | 278 Million USD | -7.33% |
| 2006 Q3 | 240 Million USD | -18.64% |
| 2006 Q2 | 295 Million USD | -22.16% |
| 2006 Q1 | 379 Million USD | 16.62% |
| 2006 Q4 | 122 Million USD | -49.17% |
| 2006 FY | 1.03 Billion USD | -27.25% |
| 2005 Q2 | 405 Million USD | -2.17% |
| 2005 Q4 | 325 Million USD | 16.07% |
| 2005 FY | 1.42 Billion USD | 14.29% |
| 2005 Q3 | 280 Million USD | -30.86% |
| 2005 Q1 | 414 Million USD | 28.57% |
| 2004 FY | 1.24 Billion USD | -6.46% |
| 2004 Q1 | 345 Million USD | 8.83% |
| 2004 Q2 | 352 Million USD | 2.03% |
| 2004 Q3 | 227 Million USD | -35.51% |
| 2004 Q4 | 322 Million USD | 41.85% |
| 2003 Q3 | 306 Million USD | 27.5% |
| 2003 Q2 | 240 Million USD | -48.83% |
| 2003 Q4 | 317 Million USD | 3.59% |
| 2003 Q1 | 469 Million USD | 559.8% |
| 2003 FY | 1.33 Billion USD | 59.9% |
| 2002 FY | 833 Million USD | -5.98% |
| 2002 Q2 | 350 Million USD | -9.09% |
| 2002 Q1 | 385 Million USD | 839.02% |
| 2002 Q3 | 200 Million USD | -42.86% |
| 2002 Q4 | -102 Million USD | -151.0% |
| 2001 Q2 | 263 Million USD | -19.33% |
| 2001 FY | 886 Million USD | 304.57% |
| 2001 Q1 | 326 Million USD | 1452.38% |
| 2001 Q4 | 41 Million USD | -83.98% |
| 2001 Q3 | 256 Million USD | -2.66% |
| 2000 Q1 | 296 Million USD | 225.27% |
| 2000 Q4 | 21 Million USD | -87.93% |
| 2000 Q3 | 174 Million USD | 163.97% |
| 2000 Q2 | -272 Million USD | -191.89% |
| 2000 FY | 219 Million USD | -66.67% |
| 1999 FY | 657 Million USD | 73.35% |
| 1999 Q3 | 138 Million USD | 30.19% |
| 1999 Q4 | 91 Million USD | -34.06% |
| 1999 Q1 | 322 Million USD | 866.67% |
| 1999 Q2 | 106 Million USD | -67.08% |
| 1998 Q2 | 78 Million USD | -60.41% |
| 1998 Q4 | -42 Million USD | -128.77% |
| 1998 FY | 379 Million USD | 224.26% |
| 1998 Q1 | 197 Million USD | 115.24% |
| 1998 Q3 | 146 Million USD | 87.18% |
| 1997 Q4 | -1.29 Billion USD | -1432.99% |
| 1997 FY | -305 Million USD | -120.27% |
| 1997 Q3 | 97 Million USD | -76.46% |
| 1997 Q2 | 412 Million USD | -13.99% |
| 1997 Q1 | 479 Million USD | 15.7% |
| 1996 Q4 | 414 Million USD | 33.12% |
| 1996 FY | 1.5 Billion USD | 56.61% |
| 1996 Q1 | 416 Million USD | 17.51% |
| 1996 Q3 | 311 Million USD | -14.56% |
| 1996 Q2 | 364 Million USD | -12.5% |
| 1995 Q2 | -18 Million USD | -106.16% |
| 1995 Q1 | 292 Million USD | 28.63% |
| 1995 FY | 961 Million USD | 52.54% |
| 1995 Q4 | 354 Million USD | 32.58% |
| 1995 Q3 | 267 Million USD | 1583.33% |
| 1994 Q4 | 227 Million USD | 48.37% |
| 1994 FY | 630 Million USD | 24.26% |
| 1994 Q1 | 45 Million USD | -89.91% |
| 1994 Q2 | 205 Million USD | 355.56% |
| 1994 Q3 | 153 Million USD | -25.37% |
| 1993 FY | 507 Million USD | 1888.24% |
| 1993 Q1 | 10.4 Million USD | 5.05% |
| 1993 Q2 | 9.7 Million USD | -6.73% |
| 1993 Q3 | -115 Million USD | -1285.57% |
| 1993 Q4 | 446 Million USD | 487.83% |
| 1992 Q4 | 9.9 Million USD | 86.79% |
| 1992 Q3 | 5.3 Million USD | -7.02% |
| 1992 Q2 | 5.7 Million USD | 23.91% |
| 1992 Q1 | 4.6 Million USD | 12.2% |
| 1992 FY | 25.5 Million USD | 67.76% |
| 1991 Q1 | 3.5 Million USD | 29.63% |
| 1991 Q2 | 3.5 Million USD | 0.0% |
| 1991 FY | 15.2 Million USD | 55.1% |
| 1991 Q3 | 4.1 Million USD | 17.14% |
| 1991 Q4 | 4.1 Million USD | 0.0% |
| 1990 Q3 | 2.9 Million USD | 26.09% |
| 1990 Q1 | 1.8 Million USD | 0.0% |
| 1990 Q2 | 2.3 Million USD | 27.78% |
| 1990 Q4 | 2.7 Million USD | -6.9% |
| 1990 FY | 9.8 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 3929.492% |
| Accuray Incorporated | -15.54 Million USD | 33821.454% |
| Align Technology, Inc. | 445.05 Million USD | -1077.837% |
| Elevance Health Inc. | 5.98 Billion USD | 12.444% |
| AxoGen, Inc. | -21.71 Million USD | 24238.884% |
| Boston Scientific Corporation | 1.59 Billion USD | -229.065% |
| CVS Health Corporation | 8.34 Billion USD | 37.176% |
| Cardinal Health, Inc. | 852 Million USD | -515.258% |
| Centene Corporation | 2.7 Billion USD | -94.004% |
| DaVita Inc. | 691.53 Million USD | -658.024% |
| Hologic, Inc. | 789.5 Million USD | -563.965% |
| Humana Inc. | 2.48 Billion USD | -110.607% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -520.324% |
| Laboratory Corporation of America Holdings | 418 Million USD | -1154.067% |
| Masimo Corporation | 81.5 Million USD | -6331.902% |
| McKesson Corporation | 3 Billion USD | -74.617% |
| Patterson Companies, Inc. | 185.93 Million USD | -2719.325% |
| Quest Diagnostics Incorporated | 854 Million USD | -513.817% |
| ResMed Inc. | 1.02 Billion USD | -413.443% |
| Henry Schein, Inc. | 416 Million USD | -1160.096% |
| Teladoc Health, Inc. | -220.36 Million USD | 2478.748% |
| Universal Health Services, Inc. | 717.79 Million USD | -630.292% |
| Veeva Systems Inc. | 525.7 Million USD | -897.137% |
| Baxter International Inc. | 2.65 Billion USD | -97.364% |
| Becton, Dickinson and Company | 1.48 Billion USD | -253.235% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -191.546% |
| Danaher Corporation | 4.2 Billion USD | -24.81% |
| Stryker Corporation | 3.16 Billion USD | -65.624% |
| Medtronic plc | 3.67 Billion USD | -42.601% |